Coronary Access After Supra-Annular THV Implantation

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

July 31, 2024

Conditions
Coronary AngiographyTranscatheter Aortic Valve Replacement
Interventions
DIAGNOSTIC_TEST

Coronary Angiography

Following TAVR, the operators will attempt to selectively engage both the right and left coronary arteries. Catheter choice and engagement technique will be at the discretion of the operator.

Trial Locations (4)

17101

NOT_YET_RECRUITING

UPMC Harrisburg, Harrisburg

V5Z 1M9

RECRUITING

Vancouver General Hospital, Vancouver

V6Z 1Y6

RECRUITING

St. Paul's Hospital, Vancouver

M4N 3M5

NOT_YET_RECRUITING

Sunnybrook Health Sciences Centre, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

collaborator

The Centre for Cardiovascular Innovation - Centre d'Innovation Cardiovasculaire (CCI-CIC)

UNKNOWN

lead

University of British Columbia

OTHER

NCT05075590 - Coronary Access After Supra-Annular THV Implantation | Biotech Hunter | Biotech Hunter